3653 results for «235»
3653 results
Expanding the spectrum of TEER suitability
18 Feb 2023 – From PCR Tokyo Valves 2023
Join this session to delve into diverse Transcatheter Edge-to-Edge Repair (TEER) scenarios, covering optimal patient groups for MitraClip therapy, insights from the EXPAND G4 study and the meticulous choice of four clip sizes for varying valve anatomies.
Clinical cases - Structural interventions - Session 7
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Structural interventions - Session 9
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 8
07 Oct 2022 – From AICT-AsiaPCR 2022
TAVI
18 Feb 2023 – From PCR Tokyo Valves 2023
Discover a selection of cases exploring TAVI at PCR Tokyo Valves 2023 in this session: long-term survival assessment after TAVI, cerebral embolic protection devices for stroke prevention, ultrasound-guided vs. conventional MANTA vascular closure devices, and more!
AICT-AsiaPCR 2023 Opening Ceremony
21 Sep 2023 – From AICT-AsiaPCR 2023
This opening ceremony of the 2023 edition of the AICT-AsiaPCR congress provides an opportunity for its Directors and co-Directors to present the programme, of course, but also to offer several prestigious awards, to introduce the Asian Pacific Society of Interventional Cardiology (APSIC) and its missions, and...
Percutaneous treatment of pure aortic regurgitation: a new indication
21 Sep 2023 – From AICT-AsiaPCR 2023
Analyse the case of an 83-year-old male patient with history of HT, parkinson's disease and minor stroke, who presented with worsening exertional SOB, LVEF 55-60 %, dilated LV, mild MR, and severe AR, and study the different options to treat aortic regurgitation.
Valve-in-valve - LIVE case
21 Sep 2023 – From AICT-AsiaPCR 2023
An 84-year-old man, with a history of 23 Carpentier-Edwards in 2004, PPM in 2013, AF on warfarin and impaired LV function (40 %), presented with severe symptomatic stenosis of the surgical bioprosthesis.
A 23 Navitor was implanted without predilatation and with post-dilatation under cerebral protection (Sentinel).
Closure was...
EuroPCR 2026 – Long-term mortality following revascularisation for left main disease
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a meta-analysis of long-term data from 4 randomised trials investigating...
FFR or 3d-quantitative coronary angiography-based vessel-FFR guided revascularisation – The FAST III trial
28 Mar 2026
Chiara De Biase provides her take on the FAST III Trial presented by Joost Daemen at ACC.26 in New Orleans. She reviews the comparison between vFFR and FFR, highlighting key findings and their impact on revascularisation strategies.
Author
BYPASS-CTCA: The value of computed tomography cardiac angiography in improving patient satisfaction and reducing contrast load, procedural duration and complications in patients who had previous CABG undergoing invasive coronary angiography
19 Sep 2022
Nicola Ryan provides her take on the BYPASS-CTCA Study which was presented by Daniel A. Jones at the TCT Congress 2022.
It must be understood that the paper has yet to be published for this study therefore all assumptions are based upon the presented data.
Author
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial
29 Mar 2025
Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.
Author
INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes
03 Sep 2024
Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.
Author
